Drug Shortage Report for CAVERJECT STERILE POWDER

Last updated on 2018-06-04 History
Report ID 42319
Drug Identification Number 02215756
Brand name CAVERJECT STERILE POWDER - KIT 23.2MCG/VIAL
Common or Proper name Caverject
Company Name PFIZER CANADA ULC
Active Ingredient(s) WATER ALPROSTADIL
Strength(s) 99.1% 23.2MCG
Dosage form(s) KIT LIQUID POWDER FOR SOLUTION
Route of administration INTRACAVERNOSAL
Packaging size 5 x 20MCG
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-20
Estimated end date
Actual end date 2018-06-01
Shortage status Resolved
Updated date 2018-06-04
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-06-04 French Compare
v10 2018-06-04 English Compare
v9 2018-04-21 English Compare
v8 2018-04-20 French Compare
v7 2018-04-20 English Compare
v6 2018-04-19 English Compare
v5 2018-03-08 French Compare
v4 2018-03-08 English Compare
v3 2018-03-08 French Compare
v2 2018-03-08 English Compare
v1 2018-03-08 English Compare